छोड़कर सामग्री पर जाएँ

US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant

  • द्वारा
  • Latest News

The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits

Read More

​ The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी